| Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium IG McKeith, BF Boeve, DW Dickson, G Halliday, JP Taylor, D Weintraub, ... Neurology 89 (1), 88-100, 2017 | 3523 | 2017 |
| Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS AC Elden, HJ Kim, MP Hart, AS Chen-Plotkin, BS Johnson, X Fang, ... Nature 466 (7310), 1069-1075, 2010 | 1411 | 2010 |
| TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis VM Van Deerlin, JB Leverenz, LM Bekris, TD Bird, W Yuan, LB Elman, ... The Lancet Neurology 7 (5), 409-416, 2008 | 868 | 2008 |
| The post-GWAS era: from association to function MD Gallagher, AS Chen-Plotkin The American Journal of Human Genetics 102 (5), 717-730, 2018 | 768 | 2018 |
| Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions VM Van Deerlin, PMA Sleiman, M Martinez-Lage, A Chen-Plotkin, ... Nature genetics 42 (3), 234-239, 2010 | 607 | 2010 |
| Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated JL Robinson, EB Lee, SX Xie, L Rennert, ER Suh, C Bredenberg, ... Brain 141 (7), 2181-2193, 2018 | 547 | 2018 |
| TAR DNA-binding protein 43 in neurodegenerative disease AS Chen-Plotkin, VMY Lee, JQ Trojanowski Nature Reviews Neurology 6 (4), 211-220, 2010 | 520 | 2010 |
| Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice LM Igaz, LK Kwong, EB Lee, A Chen-Plotkin, E Swanson, T Unger, ... The Journal of clinical investigation 121 (2), 726-738, 2011 | 480 | 2011 |
| Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease JH Kang, DJ Irwin, AS Chen-Plotkin, A Siderowf, C Caspell, CS Coffey, ... JAMA neurology 70 (10), 1277-1287, 2013 | 428 | 2013 |
| Expression of TDP-43 C-terminal fragments in vitro recapitulates pathological features of TDP-43 proteinopathies LM Igaz, LK Kwong, A Chen-Plotkin, MJ Winton, TL Unger, Y Xu, ... Journal of Biological Chemistry 284 (13), 8516-8524, 2009 | 417 | 2009 |
| CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease A Siderowf, SX Xie, H Hurtig, D Weintraub, J Duda, A Chen-Plotkin, ... Neurology 75 (12), 1055-1061, 2010 | 393 | 2010 |
| APOE ϵ4 increases risk for dementia in pure synucleinopathies D Tsuang, JB Leverenz, OL Lopez, RL Hamilton, DA Bennett, ... JAMA neurology 70 (2), 223-228, 2013 | 389 | 2013 |
| Longitudinal study of normal cognition in Parkinson disease K Pigott, J Rick, SX Xie, H Hurtig, A Chen-Plotkin, JE Duda, JF Morley, ... Neurology 85 (15), 1276-1282, 2015 | 293 | 2015 |
| Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease WT Hu, DM Holtzman, AM Fagan, LM Shaw, R Perrin, SE Arnold, ... Neurology 79 (9), 897-905, 2012 | 263 | 2012 |
| TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways AS Chen-Plotkin, TL Unger, MD Gallagher, E Bill, LK Kwong, ... Journal of Neuroscience 32 (33), 11213-11227, 2012 | 233 | 2012 |
| Association of GBA mutations and the E326K polymorphism with motor and cognitive progression in Parkinson disease MY Davis, CO Johnson, JB Leverenz, D Weintraub, JQ Trojanowski, ... JAMA neurology 73 (10), 1217-1224, 2016 | 223 | 2016 |
| The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration CE Yu, TD Bird, LM Bekris, TJ Montine, JB Leverenz, E Steinbart, ... Archives of neurology 67 (2), 161-170, 2010 | 219 | 2010 |
| GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease IF Mata, JB Leverenz, D Weintraub, JQ Trojanowski, A Chen‐Plotkin, ... Movement Disorders 31 (1), 95-102, 2016 | 217 | 2016 |
| Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study MA Nalls, CY McLean, J Rick, S Eberly, SJ Hutten, K Gwinn, M Sutherland, ... The Lancet Neurology 14 (10), 1002-1009, 2015 | 217 | 2015 |
| Association of cerebrospinal fluid neurofilament light protein levels with cognition in patients with dementia, motor neuron disease, and movement disorders B Olsson, E Portelius, NC Cullen, Å Sandelius, H Zetterberg, ... JAMA neurology 76 (3), 318-325, 2019 | 206 | 2019 |
